TREATING WATER STRESS IN PLANTS
20180213793 ยท 2018-08-02
Inventors
Cpc classification
Y02P20/55
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C07H13/00
CHEMISTRY; METALLURGY
International classification
Abstract
The present invention relates to methods and uses of photo-labile compounds which are trehalose-6-phosphate or trehalose-6-phosphonate or agriculturally acceptable salts thereof in the treatment of water stress in plants. The invention also concerns methods and the use of the compounds for resurrection of water stressed plants, and for improvement of yield of crop plants under water stressed conditions compared with untreated plants.
Claims
1. Use of a compound of formula (I), a phosphonate analogue thereof, or agriculturally acceptable salts thereof: ##STR00009## wherein; p is 0 or 1; R.sub.1 to R.sub.7 independently represent F, N.sub.3, NRR, C.sub.1-4alkyl, (C.sub.1-4alkyl)OH or OH, wherein R and R independently represent hydrogen or C.sub.1-4alkyl; and R.sub.8 and R.sub.9 are the same or different and represent H or a photo-labile protecting group, wherein at least one of R.sub.8 and R.sub.9 represents a photo-labile protecting group; as a treatment for water stress in plants.
2. Use of a compound as claimed in claim 1, wherein the photo-labile protecting group is of formula (II): ##STR00010## wherein; ring A represents an aryl or heterocyclic group; either (i) R.sub.10 and R.sub.11 are the same or different and are selected from hydrogen, C.sub.1-4alkyl which is unsubstituted or substituted with one or more halogen atoms, OR, halogen, NRR or CO.sub.2R, wherein R and R are independently selected from hydrogen and C.sub.1-4alkyl, or (ii) two R.sub.10 groups on adjacent photo-labile protecting groups together form a bond and R.sub.11 represents hydrogen, C.sub.1-4alkyl which is unsubstituted or substituted with one or more halogen atoms, OR, halogen, NRR or CO.sub.2R, wherein R and R are independently selected from hydrogen and C.sub.1-4alkyl; n is 0 or 1; and R.sub.12 and R.sub.13 are the same or different and are selected from hydrogen, C.sub.1-4alkyl which is unsubstituted or substituted with one or more halogen atoms, OR, halogen, NRR or CO.sub.2R, wherein R and R are independently selected from hydrogen and C.sub.1-4alkyl; wherein X represents the link to the remainder of the compound of formula (I).
3. Use of a compound as claimed in claim 1 or claim 2, wherein the photo-labile group is selected from; ##STR00011## wherein X represents the link to the remainder of the compound of formula (I).
4. Use of a compound as claimed in any of claims 1 to 3, wherein the photo-labile protecting group is of formula (III): ##STR00012## wherein either Z represents N, Y represents CR.sub.36 and Z and Y are linked by a double bond; or Z represents O, Y represents CO and Z and Y are linked by a single bond; R.sub.36 represents CR.sub.37R.sub.38X; when Y represents CR.sub.36, R.sub.35 represents hydrogen, and when Y represents CO, R.sub.35 represents CR.sub.37R.sub.38X; either (i) R.sub.37 and R.sub.38 are the same or different and are selected from hydrogen, C.sub.1-4alkyl which is unsubstituted or substituted with one or more halogen atoms, OR, halogen, NRR or CO.sub.2R, wherein R and R are independently selected from hydrogen and C.sub.1-4alkyl, or (ii) two R.sub.37 groups on adjacent photolabile protecting groups together form a bond and R.sub.38 represents hydrogen, C.sub.1-4alkyl which is unsubstituted or substituted with one or more halogen atoms, OR, halogen, NRR or CO.sub.2R, wherein R and R are independently selected from hydrogen and C.sub.1-4alkyl; R.sub.32 represents OR, NRR, O(C.sub.1-4alkyl)-COOR, O(C.sub.1-4alkyl)-OR or O(C.sub.1-4alkyl)-NRR, wherein R and R independently represent hydrogen or C.sub.1-4alkyl; and R.sub.31, R.sub.33 and R.sub.34 are independently selected from hydrogen, halogen, OR, NRR, O(C.sub.1-4alkyl)-COOR, O(C.sub.1-4alkyl)-OR or O(C.sub.1-4alkyl)-NRR, wherein R and R independently represent hydrogen or C.sub.1-4alkyl; wherein X represents the link to the remainder of the compound of formula (I).
5. Use of a compound as claimed in any preceding claim, wherein; the photo-labile protecting group is selected from the group consisting of: ##STR00013## ##STR00014##
6. Use of a compound as claimed in claim 2, wherein the photo-labile protecting group is of formula (II) and ring A represents a C.sub.6-10 aryl group or a 5- to 14-membered heterocyclic group containing one or more atoms selected from N, O and S, wherein the aryl or heterocyclic group is unsubstituted or substituted with one or more substituents selected from C.sub.1-4alkyl, OR, halogen, CN, NRR, COOR, (C.sub.1-4alkyl)COOR, and O(C.sub.1-4alkyl)COOR, wherein R and R are independently selected from hydrogen and C.sub.1-4alkyl, or wherein two adjacent substituents on the aryl or heterocyclic group together form a 5- or 6-membered heterocyclic ring containing one or more heteroatoms selected from N, O or S.
7. Use of a compound as claimed in any of claims 2 to 5, wherein the photo-labile protecting group is of formula (II) and ring A represents a phenyl, naphthalenyl or dibenzofuranyl ring.
8. Use of a compound as claimed in any preceding claim, wherein the photo-labile protecting group is of formula (IIa): ##STR00015## wherein; ring A represents an unsubstituted or substituted group selected from phenyl, naphthyl or dibenzofuranyl, wherein a substituted phenyl, naphthyl or dibenzofuranyl group is a phenyl, naphthyl or dibenzofuranyl group having one or two methoxy substituents or a phenyl, naphthyl or dibenzofuranyl wherein two adjacent ring positions are substituted with a CH.sub.2OCH.sub.2 moiety; and the R.sub.10 represents hydrogen, methyl, CF3 or COOH; wherein X represents the link to the remainder of the compound of formula (I).
9. Use of a compound as claimed in claim 2, wherein the photo-labile protecting group is of formula (IIIa): ##STR00016## wherein; R.sub.32 represents OR, NRR or O(C.sub.1-4alkyl)-COOR, wherein R and R independently represent hydrogen or C.sub.1-2alkyl; and R.sub.33 represents hydrogen, Br, OR, NRR, or O(C.sub.1-4alkyl)-COOR, wherein R and R independently represent hydrogen or C.sub.1-2alkyl; wherein X represents the link to the remainder of the compound of formula (I).
10. Use of a compound as claimed in claim 9, wherein; a) R.sub.33 represents H and R.sub.32 represents OMe, NMe.sub.2, NEt.sub.2 or OCH.sub.2COOH; or b) R.sub.33 represents Br and R.sub.32 represents OH; or c) R.sub.33 and R.sub.32 both represent OCH.sub.2COOH.
11. Use of a compound as claimed in any preceding claim, wherein R.sub.1 to R.sub.7 represent hydroxyl.
12. Use of a compound as claimed in any preceding claim, wherein p is 1.
13. Use of a compound as claimed in any preceding claim, wherein the plant is a monocotyledonous plant.
14. Use of a compound as claimed in claim 13, wherein the plant is a cereal crop selected from the genera Triticum, Zea, Oryza, Hordeum, Sorghum, Panicum, Avena, or Secale; preferably wherein the plant is a Triticum spp. plant.
15. A method of treating a water stressed plant, wherein the method comprises treating the plant with a compound as defined in any of claims 1 to 12.
16. A method of resurrecting a water stressed plant, wherein the method comprises treating the plant with a compound as defined in any of claims 1 to 12.
17. A method as claimed in claim 15 or claim 16, wherein the method comprises treating the plant in a vegetative growth phase.
18. A method as claimed in any of claims 15 to 17, wherein the method comprises treating the plant with the compound at least 24 hours prior to re-watering.
19. A method as claimed in any of claims 15 to 18, wherein the plant is under water stress for a period falling in the range of 8 hours to 10 days.
20. A method as claimed in any of claims 15 to 19, wherein the compound is applied together with at least one fertilizer, fungicide, herbicide, insecticide or plant growth regulator.
21. A method as claimed in any of claims 15 to 20, wherein the plant is a monocotyledonous plant.
22. A method as claimed in claim 21, wherein the plant is a cereal crop selected from the genera Triticum, Zea, Oryza, Hordeum, Sorghum, Panicum, Avena, or Rye; preferably wherein the plant is a Triticum spp. plant.
23. A method as claimed in any of claims 15 to 22, wherein the plant has increased growth, biomass and/or yield compared with untreated plants.
24. A method of improving crop yield of field grown crops, comprising treating the growing crop in a vegetative phase prior to flowering with a compound as defined in any of claims 1 to 12.
25. A method as claimed in claim 24, wherein the crop is treated at least 8 hours following onset of water stress.
26. A method as claimed in claim 24 or claim 25, wherein the crop is treated at least 24 hours prior to re-watering.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0057] The invention will now be described in detail with reference to Examples and with reference to the accompanying drawings, in which:
[0058]
[0059]
[0060]
[0061]
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
DETAILED DESCRIPTION
Examples
[0101] The trehalose 6-phosphate (T6P) synthesis pathway in plants is summarized in
Example 1. Design and Synthesis of Signalling Precursors of T6P
[0102] T6P is plant impermeable (
[0103] Synthesis of signalling-precursor compounds 1-4
[0104] 1H-tetrazole solution (0.45 M in CH.sub.3CN) (0.6 mL, 0.24 mmol, 2.0 equiv.) was added into a stirred solution of 12 (100 mg, 0.12 mmol, 1 equiv.) and bis-(2-nitrobenzyl)-N,N-diisopropylphosphoramidite 9 (78.3 mg, 0.18 mmol, 1.5 equiv.) in anhydrous CH.sub.2Cl.sub.2 (5 mL) under an argon atmosphere at 0 C. The resulting reaction mixture was stirred at 0-5 C. and progress of the reaction was monitored by TLC (petroleum ether:ether; 8:2) and mass spectrometry. After complete disappearance of starting material (1 h), tBuOOH (0.1 mL) was added at 0 C. and stirring was continued for another 30 min. After 30 min the reaction mixture was concentrated in vacuo and the residue was suspended in methanol (2 mL) and stirred in the presence of 30 mg of Dowex-H.sup.+ resin for 1 h at room temperature to globally remove TMS groups.
[0105] Dowex-H.sup.+ was removed through filtration and the filtrate was concentrated, which on flash chromatography (water:isopropanol:ethyl acetate, 1:2:8) purification yielded 1 (70 mg) in 87% isolable yield. Similar reaction protocols were adopted for the synthesis of compounds 2 and 3. Compound 4 was obtained when a stirred solution of 12 (100 mg, 0.12 mmol) in pyridine (2 mL) at room temperature was treated with POCl.sub.3 (0.012 mL, 0.132 mmol) for 10 min followed by addition of 4,5-dimethoxy-2-nitrobenzyl alcohol (76.7 mg, 0.36 mmol) and continuous stirring for 1 h.
[0106] The resulting reaction mixture was concentrated in vacuo to yield crude product mixture, which was treated with Dowex-H.sup.+ (30 mg) in methanol (2 mL). After filtration, concentration in vacuo and flash chromatography purification yielded 4 (45 mg, 62%) as a pure sticky solid. Full details of the synthesis of each of the compounds are provided below.
Synthetic Protocols, Experimental and Characterization Data for all Compounds
Synthesis of Bis-2-Nitrobenzyl-N,N-Diisopropylphosphoramidite 9
[0107] Diisopropylphosphoramidous dichloride 5 (2.0 g, 9.90 mmol) was dissolved in 15 mL of THF and the resulting solution was added slowly to a solution containing 4.2 mL (29.7 mmol) of triethylamine and 3.03 g (19.8 mmol) of 2-nitrobenzyl alcohol 6 in 10 mL of THF at 0 C. The reaction mixture was stirred at 0 C. for 30 min and then at 25 C. for another 2 h. The colorless precipitate was isolated by filtration and the solid was washed with 100 mL of ethyl acetate. The organic phase was washed successively with 15 mL portions of saturated NaHCO.sub.3 and saturated NaCl and then dried (MgSO4) and concentrated under reduced pressure at 25 C. The residue was precipitated from ethyl acetate/hexane, affording bis (2-nitrobenzyl) N,N-diisopropylphosphoramidite 9 (3.0 g, 70%) as a colorless solid..sup.5 (see
bis-(2-nitrobenzyl)-N,N-diisopropylphosphoramidite 9
[0108] Mp 71-72 C. [lit..sup.5 Mp 71-73 C.] 1H NMR (400 MHz, CDCl.sub.3) 8.10 (d, J=8.4 Hz, 2H, H-3 and H-3), 7.86 (d, J=8.0 Hz, 2H-6 and 11-6), 7.67 (t, J=8.0 Hz, 2H, H-5 and H-5), 7.44 (t, J=8.4 Hz, 211, 11-4 and H-4), 5.21 (dd, J=16.4 Hz and J=6.8 Hz, 211, CH.sub.2Ar), 5.12 (dd, J=16.4 Hz and J=6.8 Hz, 2H, CH.sub.2Ar), 3.77-3.71 (m, 2H, 2CH(CH.sub.3).sub.2), 1.25 (d, J=8.5 Hz, 12H, 2CH(CH.sub.3).sub.2); .sup.13C NMR (100 MHz, CDCl.sub.3) 146.8 (C-2 and C-2), 136.1, 136.0 (C-I and C-I), 133.7 (C-6 and C-6), 128.5 (C-5 and C-5), 127.8 (C-4 and C-4), 124.6 (C-3 and C-3), 62.5 (CH.sub.2Ar), 62.3 (CH.sub.2Ar), 43.4 (CH(CH.sub.3).sub.2), 43.3 (CH(CH.sub.3).sub.2), 24.7 (CH(CH.sub.3).sub.2), 24.6 (CH(CH.sub.3).sub.2); .sup.31P NMR (162 MH, CDCl.sub.3) 149.0; ESI-LRMS m/z calculated for C.sub.20H.sub.26N.sub.3O.sub.6P [M+H].sup.+ 436.1; Found 436.1.
Synthesis of bis-(4,5-dimethoxy-2-nitrobenzyl)-N,N-diisopropylphosphoramidite 10
[0109] To a 20 C. cooled suspension of 4,5-dimethoxy-2-nitrobenzyl alcohol 7 (2.1 g, 9.90 mmol) and triethylamine (1.5 mL, 10.8 mmol) in dry THF (10 mL) was added dropwise a solution of diisopropylphosphoramidous dichloride 5 (1.0 g, 4.95 mmol) in dry THF (2 mL). The mixture was allowed to warm to 20 C., stirred for 18 h, and a saturated solution of aq. NaHCO.sub.3, (15 mL) added. The solid was filtered, washed with water (20 mL) and dried to give 2.0 g (74%) of 10.sup.6. (see
bis-(4,5-dimethoxy-2-nitrobenzyl)N,N-diisopropylphosphoramidite 10
[0110] .sup.1H NMR (400 MHz, CDCl.sub.3) 7.72 (s, 2H, H-3 and H-3), 7.39 (s, 2H, H-6 and H-6), 5.24 (dd, J=16.4 Hz and J=6.8 Hz, 2H, CH.sub.2Ar), 5.15 (dd, J=16.4 Hz and J=6.8 Hz, 2H, CH.sub.2Ar), 3.95 (s, 6H, 2OMe), 3.94 (s, 6H, 2OMe), 3.85-3.70 (m, 2H, 2CH(CH.sub.3).sub.2) 1.27 (d, J=8.5 Hz, 12H 2CH(CH.sub.3).sub.2); .sup.13C NMR (100 MHz, CDCl.sub.3) 153.8 (C-5 and C-5), 147.5 (C-4 and C-4), 138.6 (C-2 and C-2), 131.7, 131.6 (C-3 and C-3), 109.2 (C-1 and C-1). 107.8 (C-6 and C6), 62.5 (CH.sub.2Ar), 62.4 (CH.sub.2Ar), 56.3 (OMe). 43.4 (CH(CH.sub.3).sub.2), 43.3 (CH(CH.sub.3).sub.2), 25.6 (CH(CH.sub.3).sub.2), 24.7 (CH(CH.sub.3).sub.2); .sup.31NMR (162 MHz, CDCl.sub.3) 147.4; ESI-LRMS m/z calculated for C.sub.24H.sub.34N.sub.3O.sub.10P [M+H].sup.+: 556. L; Found 556.1.
Synthesis of bis-[1-(2-nitrophenyl)-ethyl]N,N-diisopropylphosphoramidite 11
[0111] Diisopropylphosphoramidous dichloride 5 (1.0 g, 4.95 mmol) was dissolved in 5 mL of dry THF and the resulting solution was added slowly to a solution containing 1.5 mL (10.89 mmol) of triethylamine and 1.65 g (9.90 mmol) of 1-methyl-2-nitrobenzyl alcohol 8 in 10 mL of THF at 0 C., The reaction mixture was stirred at 0 C. for 1 min and then at 25 C. for another 18 h. The reaction mixture was diluted with EtOAc. The organic phase was washed successively with 15 mL portions of saturated NaHCO.sub.3 and saturated NaCl and then dried (MgSO4) and concentrated under reduced pressure at 25 C. to get crude product. The residue was purified by flash column chromatography using ethyl acetate/petroleum ether (5:95 v/v), affording bis-[1-(2-nitrophenyl)-ethyl]-N, N-diisopropylphosphoramidite 11 (1.6 g, 72%) as a colorless solid. (see
Bis-[1-(2-nitrophenyl)-ethyl)-N, N-diisopropylphosphoramidite 11
[0112] Isolated as a dia-stereomeric mixture. .sup.1H NMR (400 MHz, CDCl.sub.3) 7.83-7.76 (m, 3H, H-3, H-3 and H-5), 7.54-7.46 (m, 3H, H-5, H-4 and H-4), 7.33-7.18 (m, 2H, H-6 and H-6). 5.48-5.29 (m, 2H, CH(CH.sub.3)Ar), 3.62-3.44 (m, 2H, 2CH(CH.sub.3).sub.2), 1.55-1.48 (m, 3H, CH(CH.sub.3)Ar), 1.40-1.35 (m, 3H, CH(CH.sub.3)Ar), 1.13-1.07 (m, 6H, CH (CH.sub.3).sub.2), 0.90-0.83 (m, 6H, CH(CH.sub.3).sub.2).sub.; .sup.13C NMR (100 MHz, CDCl.sub.3).sup.5 147.2, 147.1, 146.9 (C-2 and C-2), 141.3. 141.1, 140.8 (C-1 and C-1), 133.4, 133.3 (C-3 and C-3), 128.5, 128.3 (C-5 and C-5), 127.8, 127.7 (C-4 and C-4), 124.0, 123.9 (C-6 and C-6), 67.3, 67.2 (CH(CH.sub.3)Ar), 67.0, 66.7 (CH(CH.sub.3), 43.1. 43.0, 25.1, 25.0 (CH(CH.sub.3).sub.2), 24.5, 24.4 (CH(CH.sub.3).sub.2), 24.2. 24.1 (CH(CH.sub.3)Ar); ESI-LRMS m/z calculated for C.sub.22H.sub.30N.sub.3O.sub.6P [M+11].sup.+; 464.1; Found 464.1.
Synthesis of Compound 1
[0113] To a solution of 12 (100 mg, 0.12 mmol, 1 equiv.) and 1H-tetrazol solution (16.8 mg, 0.24 mmol, 2.0 equiv. 0.5 mL of 0.4M solution in CH.sub.3CN) in anhydrous CH.sub.2Cl.sub.2 (4 mL) under an argon atmosphere at 0 C.m bis-(2-nitrobenzyl) N,N-diisopropylphosphoramidite 9 (78.3 mg, 0.18 mmol, 1.5 equiv.) was added. The solution was stirred for 30 min and progress of the reaction was monitored by TLC (petroleum ether:ether; 8:2). After complete disappearance of starting material, tBuOOH (32.5 mg, 0.36 mmol, 3.0 equiv 0.1 mL of 5M solution in decane) was added at 0 C. and stirred for 30 min. After 30 min the reaction mixture was concentrated in vacuo and the residue was stirred with 30 mg of Dowex-H.sup.+ resin in methanol (10 mL) for 1 h to obtain deprotected compound as a crude product. This crude product after flash chromatography purification yielded desired product 1 (70 mg) in 87% isolable yield. (see
6-O-bis-(2-nitrobenzyloxyphosphoryl)-D-trehalose 1
[0114] R.sub.f 0.60 (1 water:2 isopropanol:4 ethyl acetate); [].sub.D.sup.21+80.6 (c 1.0, MeOH); FT-IR (ATR) cm.sup.1 (3347 (br, OH), 1526 (s, NO), 1343 (s, NO), 1255 (PO); .sup.1H NMR (500 MHz, D.sub.2O) 8.02 (d, J=8.0 Hz, 2H ArH), 7.66-7.65 (m, 4H, ArH), 7.50-7.46 (m, 2H, ArH), 5.43 (d, J=7.2 Hz, 4H, 2(CH.sub.2Ar), 4.96 (d, J.sub.1,2=3.6 Hz, 1H, H-1), 4.93 (d, J.sub.1,2=3.6 Hz, 1H, H-1), 4.40 (dd, J.sub.6a,6b=11.0 Hz, J.sub.6a,5=2.0 Hz, 1H, H-6a), 4.35 (dd, J.sub.6B,6a=11.0 Hz, J.sub.6b,5=4.5 Hz, 1H, H-6b), 3.93 (td, J.sub.54=10.0 Hz and J.sub.5,6a=2.0 Hz, 1H, H-5), 3.71 (t, J.sub.32=9.2 Hz, J.sub.3,4=9.2 Hz, 1H, H-3), 3.70-3.68 (m, 1H, H-5), 3.67 (t, J.sub.3,2=9.6 Hz, J.sub.3,4=9.6 Hz, 1H, H-3), 3.66-3.65 (m, 1H, H-6a), 3.58 (dd, J.sub.6b,6a=12.0 Hz and J.sub.6b,5=5.2 Hz, 1H, H-6b), 3.44 (dd, J.sub.23=9.9 Hz, J.sub.2,1=3.5 Hz, 1H, H-2), 3.40 (dd, J.sub.2,3=9.6 Hz, J.sub.2,1=3.8 Hz, 1H, H-2), 3.27 (t, J.sub.43=9.6 Hz, J.sub.45=9.6 Hz, 1H, H-4), 3.22 (t, J.sub.4,3=9.6 Hz, J.sub.4,5=9.6 Hz, 1H, H-4); .sup.13C NMR (125 MHz, D20) 147.7 (qCAr), 134.3 (qCAr), 132.1 (ArC), 132.0 (ArC), 129.4 (ArC), 129.0 (ArC), 128.9 (ArC), 125.0 (ArC), 94.4 (C-1), 94.3 (C-1), 73.5 (C-3), 73.3 (C-3), 72.8 (C-2), 72.1 (C-2), 72.0 (C-5), 71.0 (C-5), 70.9 (C-4), 70.8 (C-4), 70.1 (C-6), 67.2 (CH.sub.2Ar), 66.6 (CH.sub.2Ar), 61.6 (C-6); .sup.31P NMR (162 MHz, D.sub.2O) 0.11; ESI-HRMS m/z calculated for C.sub.26H.sub.33N.sub.2O.sub.18P [M+Na].sup.+715.1368; Found 715.1368.
Synthesis of Compound 2
[0115] To a solution of 12 (100 mg, 0.12 mmol, 1 equiv.) and 1H-tetrazol (84 mg, 1.2 mmol, 10 equiv. 3.0 mL of 0.4 M solution in CH.sub.3CN) in anhydrous CH.sub.2Cl.sub.2 (8 mL) under an argon atmosphere at 0 C., bis-(4,5-dimethoxy-2-nitrobenzyl)-N,N-diisopropylphosphoramidite 10 (100 mg, 0.18 mmol, 1.5 equiv.) was added and the resulting reaction mixture was stirred at 0-5 C. The progress of the reaction was monitored by TLC (petroleum ether:ether; 8:2). After complete disappearance of starting material (18 h), tBuOOH (32.5 mg, 0.36 mmol, 3.0 equiv. 0.1 mL of 5M solution in decane) was added at 0 C. and the mixture stirred for a further 30 min. After 30 min the reaction mixture was concentrated in vacuo and the residue was stirred with 30 mg of Dowex-H.sup.+ resin in methanol (10 mL) for 1 h to obtain deprotected compound as crude product. This crude product after flash chromatography purification yielded desired product 2 (50 mg) in 52% isolable yield. (see
6-O-bis-(4,5-dimethoxy-2-nitrobenzyloxyphosphoryl)-D-trehalose 2
[0116] R.sub.f 0.50 (1 water; 2 isopropanol:4 ethyl acetate); [].sub.D.sup.21+64.8 (c 1.1, MeOH); FT-IR (ATR) cm.sup.1 3347 (br, OH), 1519 (s, NO), 1326 (s, NO), 1220 (PO): .sup.1H NMR (500 MHz, CD.sub.3OD) 7.53 (s, 2H, ArH), 7.03 (s, 2H, ArH), 5.37 (d, J=8.0 Hz, 4H, 2CH2Ar), 4.95 (d, J.sub.12=4.0 Hz, 1H, H-1), 4.91 (d, J.sub.1,2=4.0 Hz, 1H, H-1), 4.30 (dd, J.sub.6a, 6b=11.6 Hz, J.sub.6a,5=2.0 Hz, IH, H-6a), 4.35 (dd, J.sub.6b,6a=11.0 Hz, J.sub.6b,5=3.6 Hz, 1H. H-6b), 3.94 (td, =10.0 Hz and J.sub.5,6a=2.0 Hz, 1H, H-5), 3.71 (t, J.sub.3,2=9.6 Hz, J.sub.3,4=9.6 Hz, 1H, H-3), 3.70-3.68 (m, 1H, H-5), 3.67 (t, J.sub.32=9.6 Hz, J.sub.3,4=9.6 Hz, 1H, H-3), 3.66-3.65 (m, 1H, H-6a), 3.58 (dd, J.sub.6b,6a=11.6 Hz and J.sub.6b,5=5.6 Hz, 1H, H-6b), 3.35 (dd, J.sub.23=8.4 Hz, J.sub.2,1=4.0 Hz, 1H, H-2), 3.33 (dd, J.sub.2,3=8.5 Hz, J.sub.2.1=3.8 Hz, 1H, H-2), 3.26 [t, J.sub.4,3=8.8 Hz, J.sub.45=8.8 Hz, 1H, H-4), 3.24 (t, J.sub.4,3.sup.=9.6 Hz, J.sub.4.5=9.6 Hz, 1H, H-4); .sup.13C NMR (125 MHz, CD.sub.3OD) 154.2 (qCAr), 148.9. (qCAr), 143.7 (qCAr), 139.6 (ArC), 126.8 (ArqC), 126.6 (ArC), 110.4 (ArC), 110.3 (ArC), 108.2, 94.4 (C-1), 94.3 (C-1), 73.5 (C-3), 73.3 (C-3), 72.8 (C-2), 72.1 (C-2), 72.0 (C-5), 70.8 (C-5), 70.2 (C-6), 69.7 (CH.sub.2Ar), 66.6 (CH.sub.2Ar), 61.6 (C-6), 56.1 (2OMe), 55.8 (2OMe); .sup.31P NMR (162 MHz CD.sub.3OD) 0.15; ESI-HRMS m/z calculated for C.sub.30H.sub.41N.sub.2O.sub.22P [M+Na].sup.+; 835.1786; Found 835.1782.
Synthesis of Compound 3
[0117] To a solution of 12 (100 mg, 0.12 mmol, 1 equiv.) and 1H-tetrazol (84 mg, 1.2 mmol, 10 equiv. 3.0 mL of 0.4 M solution in CH.sub.3CN) in anhydrous CH.sub.2Cl.sub.2 (8 mL) under an argon atmosphere at C., bis-[1-(2-nitrophenyl)-ethyl]-N,N-diisopropylphosphoramidite 11 (83.5 mg, 0.18 mmol, 1.5 equiv.) was added and the resulting reaction mixture was stirred at 0-5 C. The progress of the reaction was monitored by TLC (petroleum ether:ether; 8:2) and mass spectrometry. After complete disappearance of starting material (18 h), tBuOOH (32.5 mg, 0.36 mmol, 3.0 equiv. 0.1 mL of 5M solution in decane) was added at 0 C. and stirred for 30 min. After 30 min the reaction mixture was concentrated in vacuo and the residue was stirred with 30 mg of Dowex-H.sup.+ resin in methanol (10 mL) for 1 h to obtain deprotected compound as crude product. This crude product after flash chromatography purification yielded desired product 3 (44 mg) in 52% isolable yield. (see
6-O-bis[1-(2-nitrophenyl)-ethoxyphosphoryl]-
[0118] Isolated as mixture of four diastereomers. R.sub.f0.65 (1 water:2 isopropanol:4 ethyl acetate); FT-IR (ATR) cm.sup.1 3394 (br, OH), 1521 (s, NO), 1326 (s, NO), 1276 (PO); .sup.1H NMR (500 MHz, CD.sub.3OD) 7.91-7.05 (m, 8H, ArH), 5.92-5.84 (m, 2H, 2CHMe), 5.04-4.94 (in, 2H, H-1 and H-1), 3.90-3.60 (m, 7H), 3.41-3.05 (m, 5H), 1.56-1.46 (m, 6H, 2CHMe); .sup.13C NMR (125 MHz, CD.sub.3OD 148.8, 148.3, 148.2 148.1 (qCAr), 147.9, 145.4, 138.9, 138.3 (qCAr), 138.2, 135.4, 135.3, 135.2 (ArC), 130.4, 130.3, 129.9, 129.3, 129.2, 128.8 (ArC) 128.7, 128.6, 126.3, 125.6, 125.5 (ArC), 95.4 (C-1), 95.3 (C-1), 79.8, 74.6 (C-3), 74.4, 74.2, (C-3), 74.0, 73.9 (C-2), 73.6, 73.3 (C-2), 73.2, 73.1 (C-5), 73.0, 72.9 (C-5), 71.9, 71.8 (C-4), 71.2, 71.1 (C-4), 71.0 (C-6), 68.5, 68.4 (CHMe.sub.2), 68.2, 68.1 (CHMe.sub.2), 62.6, 62.1 (C-6), 30.7, 30.5, 24.7 (CHCH.sub.3), 24.6, 23.5, 23.7 (CHCH.sub.3); .sup.31P NMR (162 MHz, CD.sub.3OD) 1.70, 2.20, 2.50, 2.81 (PO) four peaks from different diastereometers; ESI-HRMS m/z calculated for C.sub.28H.sub.37N.sub.2O.sub.18P [N+Na].sup.+: 743.1677; Found 743.1676.
Synthesis of Compound 4
[0119] To a stirred solution of compound 12 (100 mg, 0.12 mmol) in pyridine (2 mL) at room temperature, POCl.sub.3 (0.012 mL, 0.132 mmol) was added dropwise and the mixture was stirred for a further 10 min. After 10 min 4,5-dimethoxy-2-nitrobenzyl alcohol (DMNB-OH) (76.7 mg, 0.36 mmol) was added and the reaction mixture stirred for further 1 h. The reaction mixture was concentrated in vacuo to get crude product mixture, which after treatment with Dowex-H.sup.+ (50 mg) in methanol (2 mL) furnished compound 2 and 4. After filtration, concentration in vacuo and flash chromatography purification yielded 4 (45 mg, 62%) as a gum. (see
6-O-(4,5-dimethoxy-2-nitrobenzyloxyphosphoryl)-
[0120] R.sub.f 0.33 (1 water:2 isopropanol:4 ethyl acetate); [].sub.D.sup.21+48.7 (c 1.1, MeOH); FT-IR (ATR) cm.sup.1 3312 (br, OH), 1521 (s, NO), 1326 (s, NO), 1220 (PO); .sup.1H NMR (500 MHz, CD.sub.3OD) 7.62 (s, 1H, ArH), 7.39 (s, 1H, ArH), 5.21 (d, J=6.0 Hz, 2H, CH.sub.2Ar), 4.91 (d, J.sub.1,2=4.0 Hz, 1H, H-1), 4.87 (d, J.sub.1,2=4.0 Hz, 1H, H-1), 4.14-3.98 (m, 2H, H-6), 3.88 (s, 3H, OMe), 3.80 (s, 3H, OMe), 3.71-3.65 (m, 4H, H-6a, H-3, H-3 and H-5), 3.57 (dd, J.sub.6b,6a=12.0 Hz and J.sub.6b,5=5.6 Hz, 1H, H-6b), 3.35 (dd, =7.2 Hz and J.sub.21=3.6 Hz, 1H, H-2), 3.32 (dd, J.sub.2,3=6.8 Hz and J.sub.2,1=3.4 Hz, 1H, H-2), 3.22-3.21 (m, 3H, H-4, H-4 and H-5); .sup.13C NMR (125 MHz, CD.sub.3OD) 155.5 (qC Ar), 149.0 (qC Ar) 139.9 (qC Ar), 132.1 (qC Ar), 110.8 (ArC), 109.0 (ArC), 95.3 (C-1), 95.2 (C-1), 74.4 (C-3), 74.3 (C-3), 73.7 (C-2), 73.2 (C-2), 73.1 (C-5), 72.7 (C-5), 71.8 (C-4), 71.4 (C-4), 65.9 (CH.sub.2Ar), 65.5 (C-6), 62.6 (C-6), 57.0 (OMe), 56.8 (OMe); .sup.31P NMR (162 MHz, CD.sub.3OD) 2.18 (PO): ESI-HRMS m/z calculated for C.sub.21H.sub.32NO.sub.18P [MH].sup.: 616.1279; Found 616.1273.
Synthesis of Compound 13
[0121] Methyl tetra-O-trimethylsilyl--
Methyl 2,3,4-tri-O-trimethylsilyl--
[0122] colourless solid [].sub.D.sup.21+95.3 (c 1, CHCl.sub.3), [lit.sub.2 [].sub.D.sup.21+93 (c3, CHCl.sub.3)]; .sup.1H NMR (400 MHz, CDCl.sub.3): 4.61 (d, J.sub.1,2=3.6 Hz, 1H, H-1), 3.78-3.74 (m, 2H, H-6 and H-3), 3.68 (dd, J.sub.6,5=4.4 Hz J.sub.6,6=11.6 Hz, 1H, H-6), 3.57 (ddd, J.sub.5,4=9.6 Hz, J.sub.5,6=4.3 Hz, J.sub.5,6=3.1 Hz, 1H, H-5), 3.48 (dd, J.sub.2,1=3.0 Hz, J.sub.2,3=8.4 Hz, 1H, H-2), 3.45 (dd, J=6.4 Hz, J=2.4 Hz, 1H, H-4), 3.34 (s, 3H, OMe), 0.17 (s, 9H, Si(CH.sub.3).sub.3), 0.15 (s, 9H, Si(CH.sub.3).sub.3), 0.14 (s, 9H, Si(CH.sub.3).sub.3); .sup.13C NMR (100 MHz, CDCl.sub.3); 99.6 (C-1), 74.8 (C-3), 73.7 (C-2), 71.9 (C-4), 71.5 (C-5), 61.8 (C6), 54.8 (OMe), 1.2 (s, 3C, Si(CH.sub.3).sub.3), 0.86 (s, 3C, Si(CH.sub.3).sub.3), 0.46 (s, 3C, Si(CH.sub.3).sub.3); ESI-LRMS m/z calculated for C.sub.16H.sub.38O.sub.6SI.sub.3 [M+Na].sup.+: 433.18; Found 433.20.
Synthesis of Compound 14
[0123] To a solution of 13 (100 mg, 0.24 mmol, 1 equiv.) and 1H-tetrazol (85 mg, 1.21 mmol, 5.0 equiv. 3.0 mL of 0.4M soln in CH.sub.3CN) in dry CH.sub.2Cl.sub.2 (8 mL) under an argon atmosphere at 0 C., bis-(2-nitrobenzyl)-N,N-diisopropylphosphoramidite 9 (156 mg, 0.36 mmol, 1.5 equiv.) was added. The solution was stirred overnight at 0-5 C. After complete disappearance of starting material (18 h), tBuOOH (64.8 mg, 0.72 mmol, 3.0 equiv. 0.2 ml of 5.0 M soln in decane) was added at 0 C. After 30 min of stirring the mixture was concentrated to dryness. The residue was dissolved in methanol (15 mL) and stirred with 30 mg of Dowex-H.sup.+ resin for 1 h to obtain deprotected compound. After 1 h the mixture was filtered and the filtrate was concentrated to yield deprotected crude product which on flash chromatography purification yielded desired product 14 (66 mg) in 50% isolable yield. (see
Methyl 6-O-bis-(2-nitrobenzyloxyphosphoryl)--
[0124] R.sub.f 0.50 (1 Methanol: 9 dichloromethane); [].sub.D.sup.21+49.5 (c 1.0, MeOH); FT-IR (ATR) cm.sup.1 3354 (br, OH), 1525 (s, NO), 1342 (s, NO), 1255 (PO); .sup.1H NMR (400 MHz, CD.sub.3OD): 8.00 (d, J=8.0 Hz, 2H, ArH), 7.67-7.61 (m, 4H, ArH), 7.48 (t, J=8.0 Hz, 1H, ArH), 7.47 (t, J=8.0 Hz, 1H, ArH), 5.44 (d, J=7.2 Hz, 411, 2CH.sub.2Ar), 4.50 (d, J.sub.1,2=3.6 Hz, 1H, HA), 4.31 (ddd, J.sub.6a,6b=11.2 Hz, J.sub.6a,31P=6.4 Hz, J.sub.6a,5=1.6 Hz, 111, H-6a), 4.22 (ddd, J.sub.6b,6a=12.0 Hz, J.sub.6b,31P=7.2 Hz, J.sub.6b,5=4.8 Hz, 1H, H-6b), 3.57 (ddd, J.sub.5,4=10.0 Hz, J.sub.5,6=4.8 Hz, J.sub.5,6=1.6 Hz, 1H, H-5) 3.50 (brt, J.sub.3,2=9.2 Hz J.sub.3,4=9.2 Hz, 1H, H-3), 3.24 (dd, J.sub.2,1=3.6 Hz, J.sub.2,3=9.2 Hz, 1H, H-2), 3.23 (s, 3H, OMe), 3.20 (dd, J.sub.4,3=9.2 Hz, J.sub.4,5=9.7 Hz, 1H, H-4); 13C NMR (400 MHz, CD.sub.3OD): 147.3 (qC Ar), 143.3 (qC Ar), 134.2, 132.0, 129.4, 128.8, 125.0
[0125] (ArC), 100.3 (C-1), 73.9 (C-3), 72.3 (C-2), 70.7 (C5), 70.1 (C-4), 67.9 (C-6), 66.5 (CH.sub.2Ar), 54.7 (OMe); .sup.31P NMR (162 MHz, CD.sub.3OD) 1.65; ESI-HRMS m/z calculated for C.sub.21H.sub.25N.sub.2O.sub.13P [M+Na].sup.+: 567.0986; Found 567.0983.
Synthesis of Compound 15
[0126] To a solution of 13 (100 mg, 0.24 mmol, 1 equiv.) and 1H-tetrazol (85 mg, 1.21 mmol, 5.0 equiv, 3.0 mL of 0.4M soln in CH.sub.3CN) in dry CH.sub.2Cl.sub.2 (8 mL) under an argon atmosphere at 0 C., bis-(4,5-dimethoxy-2-nitrobenzyl)-N,N-diisopropylphosphoramidite 10 (200 mg, 0.36 mmol, 1.5 equiv.) was added. The solution was stirred overnight at 0-4 C. After complete disappearance of starting material (18 h), tBuOOH (64.8 mg, 0.72 mmol, 3.0 equiv. 0.2 mL of 5.0 M soln in decane) was added at 0 C. After 30 min of stirring the mixture was concentrated to dryness. The residue was dissolved in methanol (15 mL) and stirred with 30 mg of Dowex-H.sup.+ resin for 1 h to obtain deprotected compounds. After 1 h the mixture was filtered and the filtrate was concentrated to yield fully deprotected crude product which on flash chromatography yielded desired product 15 (60 mg) in 37% isolable yield. (see
Methyl 6-O-bis-(4,5-dimethoxy-2-nitrobenzyloxyphosphoryl--
[0127] R.sub.f0.40 (1 Methanol: 9 dichloromethane); [].sub.D.sup.21+40.7 (c 1.09, MeOH); FT-IR (ATR) cm.sup.1 3355 (br, OH), 1519 (s, NO), 1326 (s, NO), 1220 (PO); .sup.1H NMR (400 MHz, CD.sub.3OD): 7.51 (s, 2H, ArH), 7.03 (s, 2H, ArH), 5.37 (d, J=8.0 Hz, 4H, 2CH.sub.2Ar), 4.50 (d, J.sub.1,2=3.6 Hz, 1H, H-1), 4.32 (ddd, J.sub.6a,6b=11.2 Hz, J.sub.6a,31P=6.4 Hz, J.sub.60=1.6 Hz, 111, H-6a), 4.22 (ddd, J.sub.6b,6a=12.0 Hz, J.sub.6b,31P=7.2 Hz, J.sub.6N5=4.8 Hz, 111, H-6b), 3.80 (s, 3H, OMe), 3.78 (s, 311, OMe), 3.57 (dd, J.sub.5,4=10.0 Hz, J.sub.5,6b=4.8 Hz, 1H, H-5), 3.50 (brt, J.sub.3,2=9.2 Hz, J.sub.3,4=9.2 Hz, 1H, H-3), 3.25 (dd, J.sub.2,1=3.6 Hz, J.sub.2,3=9.2 Hz, 1H, H-2), 3.24 (s, 3H, OMe), 3.21-3.16 (m, 1H, H-4); .sup.13C NMR (400 MHz, CD.sub.3OD): 154.1, 148.9 (qC Ar), 143.2, 139.5 (qC Ar), 126.6 110.3, 108.1 (ArC), 100.3 (C-1), 73.9 (C-3), 72.3 (C-2), 70.7 (C-5), 70.1 (C-4), 68.0 (C-6), 66.8 (CH.sub.2AR), 56.0, 55.8 (OMe), 54.7 (OMe); .sup.31P NMR (162 MHz, CD.sub.3OD) 1.62; ESI-HRMS m/z calculated for C.sub.25H.sub.33N.sub.2O.sub.17P [M+Na].sup.+ 687.1409; Found 687,1421.
Synthesis of Compound 16
[0128] To a solution of 13 (100 mg, 0.24 mmol, 1 equiv.) and 1H-tetrazol (85 mg, 1.21 mmol, 5.0 equiv, 3.0 mL of 0.4M sole in CH.sub.3CN) in dry CH.sub.2Cl.sub.2 (5 mL) under an argon atmosphere at 0 C., bis-[1-(2-nitrophenyl)-ethyl]-N,N-diisopropylphosphoramidite 11 (167 mg, 0.36 mmol, 1.5 equiv.) was added. The solution was stirred overnight (15 h) at 0-4 C. After complete disappearance of starting material, t-BuOOH (64.8 mg, 0.72 mmol, 3.0 equiv 0.2 ml of 5.0 M soln in decane) was added at 0 C. After 30 min of stirring the mixture was concentrated in vacuo. The residual mixture was deprotected by stirring in methanol (15 mL) with 25 mg of Dowex-H.sup.+ resin for 1 h. After filtration the filtrate was concentrated to yield fully deprotected crude product which on flash chromatography purification yielded desired product 16 (62 mg) in 45% yield. (see
Methyl 6-O-bis[1-(2-nitrophenyl)-ethoxyphosphoryl]--
[0129] R.sub.f 0.55 (1 Methanol: 9 dichloromethane); Isolated as a mixture of four diastereomers, FT-IR (ATR) 3334 cm.sup.2 (br, OH), 1520 (s, NO), 1325 (s, NO), 1219 (PO); .sup.1H NMR (400 MHz, CD.sub.3OD); 7.86-7.84 (m, 2H, ArH), 7.75-7.50 (m, 3H, ArH), 7.45-7.34 (m, 3H, ArH), 5.89-5.80 (m, 2H, 2CH(CH.sub.3), 4.57-4.45 (4d, J.sub.1,2=3.6 Hz, 1H, H-1), 4.16-3.89 (m, 211, 11-6), 3.51-3.40 (m, 211, 11-5 and 11-3), 3.31-3.25 (m, 1H, H-2), 3.25, 3.22 3.17, 3.13 (4s, 311, OMe), 3.16-3.12 (m, 111, 11-4), 1.68-1.57 (4d, J=6.8 Hz, 6H, 2CH(CH.sub.3): .sup.13C NMR (400 MHz, CD.sub.3OD): 137.2, 137.2, 134.3, 134.2, 129.4, 129.3, 127.8, 127.7, 127.6, 127.5, 124.6, 124.5 (ArC), 100.7, 100.3, 100.2, 100.1 (C-1), 74.0, 73.9 (C-3), 73.3, 73.2 (C-2), 72.9, 72.3 (C-5), 72.2, 70.6 (C-4), 70.5, 70.1 (C-6), 70.0, 67.4 (CH(CH.sub.3)), 55.1, 54.8, 54.7, 54.6 (OMe), 23.6, 23.5, 23.4 (CH(CH.sub.3)); .sup.31P NMR (162 MHz, CD.sub.3OD) 3.2, 3.7, 3.8, 4.0; ESI-HRMS m/z calculated for C.sub.23H.sub.29N.sub.2O.sub.13P [M+Na].sup.+: 595.1299; Found 595.1305.
Synthesis of Compound 17
[0130] To a stirred solution of compound 13 (100 mg, 0.24 mmol) in pyridine (2 mL) at room temperature POCl.sub.3 (0.024 mL, 0.26 mmol) was added and the mixture stirred. After 10 min, 4,5-dimethoxy-2-nitrobenzyl alcohol (153.4 mg, 0.72 mmol) was added and the reaction mixture was left stirring at the same temperature for 1 h. The reaction mixture was then concentrated in vacuo to yield crude product mixture, which after treatment with Dowex-H.sup.+ resin (50 mg) in methanol (2 mL) furnished compound 15 and 17. Filtration, concentration in vacuo and flash chromatography purification yielded compound 17 (55 mg, 48%) as a pure solid. (see
Methyl 6-O-(4,5-dimethoxy-2-nitrobenzyloxyphosphoryl)--
[0131] R.sub.f 0.35 (1 water:2 isopropanol:4 ethyl acetate): [].sub.D.sup.21+38.9 (c 0.64, MeOH), FT-IR (ATR) cm.sup.1 3319 (br OH), 1521 (s, NO), 1326 (s, NO), 1220 (PO); .sup.1H NMR (400 MHz, CD.sub.3OD): 7.74 (s, 1H, ArH), 7.50 (s, 1H, ArH), 5.33 (d, J=6.4 Hz, 211, CH.sub.2Ar), 4.57 (d, J.sub.1,2=3.6 Hz, 1H, H-1), 4.02 (s, 3H, OMe), 3.92 (s, 3H, OMe), 3.64-3.60 (m, 2H, H-6), 3.42 (dd, J.sub.5,4=9.6 Hz, J.sub.5,6b=2.8 Hz, 1H, H-5), 3.40 (brt, J.sub.3,2=9.2 Hz, J.sub.3,4=9.2 Hz, 1H, H-3), 3.39 (dd, J.sub.2,3=9.6 Hz, J.sub.2,1=3.0 Hz, 1H, H-2), 3.32 (s, 3H, OMe), 3.32-3.31 (m, 1H, H-4); .sup.13C NMR (400 MHz, CD.sub.3OD): 154.3, 147.9, 138.9, 131.1, 110.0, 107.9 (ArC), 100.0 (C-1), 73.6 (C-3), 72.2 (C-2), 71.3 (C-5), 70.0 (C-4), 64.8 (C-6), 64.5 (CH.sub.2Ar), 56.3 (OMe), 56.0 (OMe), 54.8 (OMe); .sup.31P NMR (162 MHz, CD.sub.3OD) 0.66; ESI-HRMS m/z calculated for C.sub.16H.sub.24NO.sub.13P [MH].sup.: 468.0907; Found 468.0905.
[0132] The .sup.1H and .sup.13C NMR. Spectra of all compounds are shown in
[0133] The signalling-precursor strategy was based on release by light (
[0134] Additionally, hydrophilic sugar molecules or charged molecules do not readily cross into plants unless actively transported. It was hypothesised that unnatural precursors could be designed that contain groups that would both mask charge/increase hydrophobicity and also be released by light. Four water-soluble precursors (1-4) of T6P were selected (
[0135] Construction of the precursors (
Example 2. Signalling Precursor Application to Water Stressed Wheat Plants
[0136] Spring wheat (Triticum aestivum Cadenza) seeds were sown in Rothamsted Prescription Compost Mix (75% medium grade (L+P) peat, 12% screened sterilised loam, 3% medium grade vermiculite, 10% grit (lime-free), 3.5 kg Osmocote Exact 3-4 month/m.sup.3 (Scott's UK Professional, Ipswich, Suffolk, www.scottinternational.com), 0.5 kg PG mix/m.sup.3 (Hydro Agri Ltd., Immingham, UK), Wetting agent and Lime) and grown in controlled environment conditions with a photoperiod of 16 hours light, 8 hours dark, day/night temperatures of 20 C./16 C., photon flux density of 600 mol m.sup.2 s.sup.1, and ambient relative humidity. Once the plants had reached Feekes stage 4, water was withheld for 10 days. On the 9th day, 30 ml 1 mM solutions of oNPE-T6P and DMNBT6P were applied to all above-ground biomass, on the 10th day the watering schedule was reinstated. Plants were harvested to measure biomass production every 5 days for 30 days after watering was reinstated. Both experiments were completed in replicates of 6.
vi) Statistical Methods
[0137] Analysis of Variance (ANOVA) was applied to data to test for differences between treatments. A natural log transformation was used where necessary to ensure constant variance. The GENSTAT statistical system was used for this analysis (2011, 14th edition, VSN International Ltd, Hemel Hempstead, UK).
[0138] The effect of the signalling precursors upon plant resilience and recovery were tested. The results are shown in
[0139] In addition, regrowth (resurrection response) of new tissue from plants that had been cut back after drought treatment was higher in T6P precursor-treated plants (